DCF — PARKVIEW MEDICAL CENTER
Enterprise Value: $118.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$118.7M
Enterprise Value
$21.5M
PV of Cash Flows
$97.3M
PV of Terminal Value
$156.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $538.6M | $24.7M | 5.0% | $-0.9M | $-0.8M |
| Year 2 | $554.7M | $31.0M | 6.0% | $3.2M | $2.7M |
| Year 3 | $571.4M | $37.6M | 7.0% | $7.6M | $5.7M |
| Year 4 | $588.5M | $41.7M | 7.0% | $10.0M | $6.8M |
| Year 5 | $606.2M | $44.4M | 7.0% | $11.5M | $7.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $118.7M. Terminal value accounts for 82% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$522.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04081602792076093
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5